Official recall notice

FDA DrugN/A

Brevital Sodium /vial Recall (Oct 2026) – Par Pharmaceutical

Product: Brevital Sodium 500 mg/vial for Injection

Recall date
2026-10-09
Category
Drug

Why it was recalled

Hazard

Presence of particulate matter identified as cellulose

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Presence of particulate matter identified as cellulose

Verify with the official notice →
Share:

Related Recalls

2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ
Sterling Pharmaceutical Services LLC
2026-09-30 · FDA_DRUG
FDA Recall: TRP The Relief Products* Gentle Eyes Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Steril
Sterling Pharmaceutical Services LLC